Skip to main content

Table 5 Comparison of the therapeutic management between survivors and non-survivors

From: Factors associated with increased pancreatic enzymes in septic patients: a prospective study

Parameters Survivors
(N = 30)
Non-survivors
(N = 20)
p
MV (N/%) 12/40 20/100 <0.001
Duration of MV (days [quartiles]) 6 [2.3–18.8] 3.5 [2–12.5] 0.344
CRRT (N/%) 10/33.3 14/70 0.011
NE (N/%) 30/100 20/100 1
NE dose (mcg/kg/min [quartiles]) 0.2 [0.09–0.42] 2 [0.7–2] <0.001
  1. MV mechanical ventilation, CRRT continuous renal replacement therapy, NE norepinephrine